Flavor improvement does not increase abuse liability of nicotine chewing gum.

What Was Tested

The paper reports a study of Therapeutic nicotine (patch, non-peptide), published as a randomized controlled trial.

Subjective, physiological, and psychomotor effects of mint flavor and original nicotine gum were tested in adult smokers (22-55 years old); a group of younger subjects (18-21 years old) was also included to allow for assessment of abuse liability in young adults specifically.

Amphetamine and confectionery gum served as positive controls for abuse liability and palatability.

Who Took Part

PubMed indexes the participants as teenagers, adults and middle-aged adults, both men and women.

How the Study Was Run

The researchers set it up as a randomized, double-blind and crossover study.

Random assignment meant chance, not the researchers, decided who got Therapeutic nicotine (patch, non-peptide) and who got the comparison, which limits bias.

Blinding on both sides kept the participants and researchers unaware of who received Therapeutic nicotine (patch, non-peptide).

Each person switched between Therapeutic nicotine (patch, non-peptide) and the comparison at some point, usually with a gap in between.

What Was Measured

Subjective, physiological, and psychomotor effects of mint flavor and original nicotine gum were tested in adult smokers (22-55 years old); a group of younger subjects (18-21 years old) was also included to allow for assessment of abuse liability in young adults specifically.

PubMed files the paper under topics including Age Factors, Analysis of Variance, Behavior, Addictive, Chewing Gum, Mentha, Nicotine and Smoking.

What This Means in Plain Language

The paper is a randomized, double-blind and crossover study of Therapeutic nicotine (patch, non-peptide).

The publication is from 2002 (Pharmacology, biochemistry, and behavior), a journal based in United States.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.